| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
IKBKG |
IKBKG, FIP3, NEMO: NF-kappa-B essential modulator |
6.202 |
Evidence |
|
| EIF4G2 |
EIF4G2, DAP5, OK/SW-cl.75: Eukaryotic translation initiation factor 4 gamma 2 |
GTF3C1 |
IPI00414481 |
6.202 |
Evidence |
|
| GNB2L1 |
Lung cancer oncogene 7 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
6.202 |
Evidence |
|
| EIF5AP1 |
EIF5A: Eukaryotic translation initiation factor 5A-1 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
6.202 |
Evidence |
|
| VASP |
VASP: Vasodilator-stimulated phosphoprotein |
CFL1 |
CFL1, CFL: Cofilin-1 |
6.202 |
Evidence |
|
| COPB2 |
COPB2: Coatomer subunit beta' |
ARFGAP1 |
IPI00175169 |
6.202 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
TRAFD1 |
TRAFD1, FLN29: TRAF-type zinc finger domain-containing protein 1 |
6.202 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
SRPK2 |
SRPK2: Serine/threonine-protein kinase SRPK2 |
6.202 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
TERF2IP |
TERF2IP, RAP1, PP8000: Telomeric repeat-binding factor 2-interacting protein 1 |
6.202 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
RNPS1 |
RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 |
6.202 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
YWHAH |
YWHAH, YWHA1: 14-3-3 protein eta |
6.202 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
MEF2A |
IPI00024072 |
6.202 |
Evidence |
|
| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
H1FX |
H1FX: Histone H1x |
6.202 |
Evidence |
|
| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
HIST3H3 |
HIST3H3, H3FT: Histone H3.1t |
6.202 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
GTF3C1 |
IPI00414481 |
6.202 |
Evidence |
|
| UNG |
IPI00011069 |
CDK6 |
CDK6: Cell division protein kinase 6 |
6.202 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
6.202 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
GNB2L1 |
Lung cancer oncogene 7 |
6.202 |
Evidence |
|
| PLEK |
PLEK, P47: Pleckstrin |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
6.202 |
Evidence |
|
| TTR |
TTR, PALB: Transthyretin precursor |
CETP |
CETP: Cholesteryl ester transfer protein precursor |
6.202 |
Evidence |
|
| TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
LGALS3BP |
LGALS3BP, M2BP: Galectin-3-binding protein precursor |
6.202 |
Evidence |
|
| SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
H1FX |
H1FX: Histone H1x |
6.202 |
Evidence |
|
| SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
GTF3C1 |
IPI00414481 |
6.202 |
Evidence |
|
| AOF2 |
AOF2, KIAA0601, LSD1: Lysine-specific histone demethylase 1 |
ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
6.202 |
Evidence |
|
| PIK3CD |
PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i |
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
6.202 |
Evidence |
|